Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma

Increased Levels of β-catenin, LEF-1, and HPA-1 Correlate with Poor Prognosis for Acral Melanoma with NegativeBRAFandNRASMutation inBRAFExons 11 and 15 andNRASExons 1 and 2

(2015) Sanxiong Xu et al.   DNA AND CELL BIOLOGY

Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer

(2015) Dingmiao Wang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma

(2015) Ning Lu et al.   TUMOR BIOLOGY

SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

(2015) Guo-Dong Song et al.   TUMOR BIOLOGY

MicroRNA-212 Inhibits Osteosarcoma Cells Proliferation and Invasion by Down-Regulation of Sox4

(2014) Xiao-Ji Luo et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

SOXC proteins amplify canonical WNT signaling to secure nonchondrocytic fates in skeletogenesis

(2014) Pallavi Bhattaram et al.   JOURNAL OF CELL BIOLOGY

Wnt/β-Catenin Signaling Pathway Inhibitors: A Promising Cancer Therapy

(2014) Ahmed F. Abdel-Magid   ACS Medicinal Chemistry Letters

GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell line

(2013) Dong-dong Cheng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Sox proteins: regulators of cell fate specification and differentiation

(2013) Y. Kamachi et al.   DEVELOPMENT

Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma

(2013) Da-min Chai et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

SOX4 Induces Epithelial-Mesenchymal Transition and Contributes to Breast Cancer Progression

(2012) J. Zhang et al.   CANCER RESEARCH

Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis

(2012) Seyed Mehdi Jafarnejad et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma

(2012) Banu Gun et al.   Diagnostic Pathology

A Review of the Association between Osteosarcoma Metastasis and Protein Translation

(2012) T.S. Osborne et al.   JOURNAL OF COMPARATIVE PATHOLOGY

SoxC Transcription Factors Are Required for Neuronal Differentiation in Adult Hippocampal Neurogenesis

(2012) L. Mu et al.   JOURNAL OF NEUROSCIENCE

The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses TH2 differentiation

(2012) Makoto Kuwahara et al.   NATURE IMMUNOLOGY

The complex world of WNT receptor signalling

(2012) Christof Niehrs   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Emerging drugs for high-grade osteosarcoma

(2010) Claudia Maria Hattinger et al.   EXPERT OPINION ON EMERGING DRUGS

Genome-Wide Promoter Analysis of the SOX4 Transcriptional Network in Prostate Cancer Cells

(2009) C. D. Scharer et al.   CANCER RESEARCH

Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma

(2009) Yongping Cai et al.   JOURNAL OF PATHOLOGY

The three SoxC proteins—Sox4, Sox11 and Sox12—exhibit overlapping expression patterns and molecular properties

(2008) Peter Dy et al.   NUCLEIC ACIDS RESEARCH

Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma

(2008) Y-L Liao et al.   ONCOGENE

Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival

(2008) Kevin Chen et al.   PEDIATRIC BLOOD & CANCER